KERI SMITH: Open Payments
NPI 1720533201 · DEMOTTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,756 in 157 payments from 35 companies in 2025. Trend: 2023 $14 · 2024 $2,301 · 2025 $4,756
Food & beverage: $4,756
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 10 | $516 |
| Novartis Pharmaceuticals Corporation | 20 | $475 |
| ARGENX US, INC. | 10 | $408 |
| JAZZ PHARMACEUTICALS INC. | 12 | $391 |
| LivaNova USA, Inc. | 2 | $276 |
| ABBVIE INC. | 18 | $272 |
| Avadel CNS Pharmaceuticals, LLC | 10 | $257 |
| Teva Pharmaceuticals USA, Inc. | 9 | $242 |
| Amgen Inc. | 2 | $231 |
| Axsome Therapeutics, Inc. | 9 | $208 |
Products named: KESIMPTA, VYVGART, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, LUMRYZ, AUSTEDO XR, EPIDIOLEX, VUMERITY, NUPLAZID.
Industry payments across IN — which companies pay providers there.
